Chandan Sanghera
Overview
Explore the profile of Chandan Sanghera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang C, Farah H, Gui H, Rezaei S, Bou-Khalil C, Park Y, et al.
NPJ Digit Med
. 2025 Mar;
8(1):149.
PMID: 40055532
Red teaming, the practice of adversarially exposing unexpected or undesired model behaviors, is critical towards improving equity and accuracy of large language models, but non-model creator-affiliated red teaming is scant...
2.
Baker A, Hartono M, Ou H, Bistrovic Popov A, Brown E, Joseph J, et al.
Angew Chem Int Ed Engl
. 2024 Apr;
63(25):e202404885.
PMID: 38622059
There is an urgent need to improve conventional cancer-treatments by preventing detrimental side effects, cancer recurrence and metastases. Recent studies have shown that presence of senescent cells in tissues treated...
3.
McClurg D, Sanghera C, Mukherjee S, Fitzgerald R, Jones C
Radiother Oncol
. 2024 Mar;
195():110224.
PMID: 38479442
Background: The availability of circulating biomarkers that are predictive of treatment response or prognostic of overall outcome could enable the personalised and adaptive use of radiotherapy (RT) in patients with...
4.
Sharma R, Inglese M, Dubash S, Lu H, Pinato D, Sanghera C, et al.
J Nucl Med
. 2020 Jun;
61(12):1743-1748.
PMID: 32513905
Accurate disease monitoring is essential after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) because of the potential for profound adverse events and large variations in survival outcome. Posttreatment changes on...
5.
Sanghera C, Sanghera R
Cureus
. 2019 Dec;
11(10):e5938.
PMID: 31788395
Immunotherapy is widely regarded to have the ability to transform the treatment of cancer, with immune checkpoint inhibitors already in use for cancers such as advanced melanoma and non-small cell...
6.
Sanghera C, Teh J, Pinato D
Liver Int
. 2019 Aug;
39(11):2008-2023.
PMID: 31433891
The pathogenesis of hepatocellular carcinoma (HCC) strongly relates to inflammation, with chronic up-regulation of pro-inflammatory mediators standing as a potential unifying mechanism that underscores the origin and progression of HCC...
7.
Sanghera C, Wong L, Panahi M, Sintou A, Hasham M, Sattler S
Dis Model Mech
. 2019 Mar;
12(3).
PMID: 30858306
Patients suffering from systemic autoimmune diseases are at significant risk of cardiovascular complications. This can be due to systemically increased levels of inflammation leading to accelerated atherosclerosis, or due to...
8.
Pereira R, Gendron T, Sanghera C, Greenwood H, Newcombe J, McCormick P, et al.
Chemistry
. 2018 Dec;
25(9):2345-2351.
PMID: 30521138
Aldehyde dehydrogenases (ALDHs) catalyze the oxidation of aldehydes to carboxylic acids. Elevated ALDH expression in human cancers is linked to metastases and poor overall survival. Despite ALDH being a poor...